Cost-effectiveness of Imaging Protocols for Suspected Appendicitis.
bit.ly shows its articles on its own site.
Read the article on bit.ly ↗Article · Mar 2020 · 1 min read
In brief
In brief
Decision-analytic model comparing 10 imaging strategies for suspected appendicitis finds that initial ultrasound followed by CT only when secondary inflammatory signs are present is most cost-effective for moderate-risk patients. The study demonstrates imaging is not cost-effective for very low or very high probability cases, supporting risk-stratified diagnostic approaches.
Written by the GCMD Library team from the article.
BACKGROUND: Inaccurate diagnosis of appendicitis leads to increased costs and morbidity. Ultrasound costs less than computed tomography (CT) or MRI but has lower sensitivity and may not visualize the appendix.
METHODS: We conducted a cost-effectiveness analysis using a decision-analytic model of 10 imaging strategies for suspected appendicitis in a hypothetical cohort of patients: no imaging with discharge or surgery; CT only; MRI only; or staged approach with CT or MRI after 1) negative ultrasound result or ultrasound without appendix visualization, 2) ultrasound without appendix visualization, or 3) ultrasound without appendix visualization but with secondary signs of inflammation. Inputs were derived from published literature and secondary data (quality-of-life and cost data). Sensitivity analyses varied risk of appendicitis and proportion of visualized ultrasound. Outcomes were effectiveness (quality-adjusted life-years [QALYs]), total direct medical costs, and cost-effectiveness (cost per QALY gained).
RESULTS: The most cost-effective strategy for patients at moderate risk for appendicitis is initial ultrasound, followed by CT if the appendix is not visualized but secondary signs are present (cost of $4815.03; effectiveness of 0.99694 QALYs). Other strategies were well above standard willingness-to-pay thresholds or were more costly and less effective. Cost-effectiveness was sensitive to patients' risk of appendicitis but not the proportion of visualized appendices.
CONCLUSIONS: Tailored approaches to imaging based on patients' risk of appendicitis are the most cost-effective. Imaging is not cost-effective in patients with a probability 95%. For moderate-risk patients, ultrasound without secondary signs of inflammation is sufficient even without appendix visualization.
doi: 10.1542/peds.2019-1352